Malignant melanoma of the oesophagus: Clinicopathological features, lack of p53 expression and steroid receptors and a review of the literature

European Journal of Surgical Oncology

Volumn 25, Issue 2, 1999, Pages 168-172

  Lam, K Y ^a,b   Law, S ^b   Wong, J ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Chinese; Incidence; Melanoma; Oesophagus; p53; Steroid receptor

Indexed keywords

ANTIBODY; ANTIGEN; ESTROGEN RECEPTOR; HMB 45; PROGESTERONE RECEPTOR; PROTEIN P53; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER STAGING; CHINESE; CLINICAL FEATURE; ESOPHAGUS; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MELANOMA; MORTALITY; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINDLE CELL; STAINING; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 0032907504     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1998.0621     Document Type: Article

References (28)

1. Moersch HJ, Broders AC. Melanoepithelioma of the esophagus. JAMA 1927; 88: 1319-20.
2. Robertson JW. Malignant melanoma of the esophagus, as one of multiple malignant tumors. Gastroenterology 1954; 27: 121-6.
3. Basque GJ, Boline JE, Holyoke JB. Malignant melanoma of the esophagus: first reported case in a child. Am J Clin Pathol 1970; 53: 609-11.
4. Suzuki H, Nagayo T. Primary tumors of the esophagus other than squamous cell carcinoma - histologic classification and statistics in the surgical and autopsied materials in Japan. Int Adv Surg Oncol 1980; 3: 73-109.
5. Kormano MJ, Yrjänä J. Radiology of uncommon esophageal neoplasms. Eur J Radiol 1981; 1: 51-6.
6. Li ZJ, Zhu ZX, Liu HR, Wang GM, Xu LT. Primary malignant melanoma of the eosophagus: report of two cases. Proc Chi Acad Sci Peking Union Med Coll 1986; 1: 180-4.
7. Taniyama K, Suzuki H, Sakuramachi S, Toyoda T, Matsuda M, Tahara E. Amelanotic malignant melanoma of the esophagus: case report and review of the literature. Jpn J Clin Oncol 1990; 20: 286-95.
8. Turnbull AD, Rosen P, Goodner JT, Beatie EJ. Primary malignant tumors of the esophagus other than typical epidermoid carcinoma. Ann Thorac Surg 1973; 15: 463-73.
9. McCormack PM, Nascimento AG, Bains MS, Knapper WH, Zaman MB. Primary melanocarcinoma of the esophagus. Clin Bull 1979; 9: 162-4.
10. Hamdy FC, Smith JH, Kennedy A, Thorpe JA. Long survival after excision of a primary malignant melanoma of the oesophagus. Thorax 1991; 46: 397-8.
11. Watanabe H, Yoshikawa N, Suzuki R, Hirai Y, Yoshie M, Ohshima H. Malignant amelanotic melanoma of the esophagus. Gastroenterol Jpn 1991; 26: 209-12.
12. Chan HS, Nambiar R. Malignant melanoma of the esophagus: a case report. Singapore Med J 1995; 36: 566-7.
13. Craig SR, Wallace WH, Ramesar KC, Cameron EW. Primary malignant melanoma of the esophagus. Hepatogastroenterology 1996; 43: 519-20.
14. Li FS, Zhang DW Primary malignant melanoma of the esophagus. Clin J Oncol 1979; 1: 71-4.
15. Baur EH, Ein fall von primaerem melanom des oesophagus. Arb Geb Pathol Anato Inst Tuebingen 1906; 5: 343-54.
16. De La Pava S, Nigogosyan G, Pickren JW, Cabrera A. Melanosis of the esophagus. Cancer 1963; 16: 48-50.
17. Tateishi R, Taniguchi H, Wada A, Horai T, Taniguchi K. Argyrophil cells and melanocytes in esophageal mucosa. Arch Pathol 1974; 98: 87-9.
18. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. Manual for Staging of Cancer. Philadelphia: JB Lippincott, 1992: 57.
19. Lam KY, Tsao SW, Zhang D, Law S, He D, Ma L, Wong J. Prevalence and predictive value of p53 mutation in patients with esophageal squamous cell carcinomas: a prospective clinicopathologic study and survival analysis of 70 patients. Int J Cancer 1997; 74: 212-9.
20. McCarty KS Jr, Szabo E, Flowers JL, et al. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res 1986; 46: 4244-8.
21. Flowers JL, Seigler HF, McCarty KS Sr, Konrath J, McCarty KS Jr. Absence of estrogen receptor in human melanoma as evaluated by a monoclonal anti-estrogen receptor antibody. Arch Dermatol 1987; 123: 764-5.
22. Duncan LM, Travers RL, Koerner FC, Mihm MC Jr, Sober AJ. Estrogen and progesterone receptor analysis in pregnancy-associated melanoma: absence of immunohistochemistry detectable hormone receptors. Hum Pathol 1994; 25: 36-41.
23. Foss AJ, Alexander RA, Guille MJ, Hungerfold JL, McCartney AC, Lightman S. Estrogen and progesterone receptor analysis in ocular melanomas. Ophthalmology 1995; 102: 431-5.
24. Ferno M, Borg A, Erichsen C, Ingvar C, Jonsson PE. Estrogen and progesterone receptors in melanoma metastases with special reference to analytical methods and prognosis. Anticancer Res 1984; 4: 179-82.
25. Walker MJ, Beattie CW, Patel MK, Ronan SM, Das Gupta TK. Estrogen receptor in malignant melanoma. J Clin Oncol 1987; 5: 1256-61.
26. Gelsleichter L, Gown AM, Zarbo RJ, Wang E, Coltrera MD. p53 and mdm-2 expression in malignant melanoma: an immunocytochemical study of expression of p53, mdm-2, and markers of cell proliferation in primary versus metastatic tumors. Mod Pathol 1995; 8: 530-5.
27. Kishore K, Ghazvini S, Char DH, Kroll S, Selle J. p53 gene and cell cycling in uveal melanoma. Am J Ophthalmol 1996; 121: 561-7.
28. Saenz-Santamaria MC, McNutt NS, Bogdany JK, Shea CR. p53 expression is rare in cutaneous melanomas. Am J Dermatopathol 1995; 17: 344-9.